SUPERNUS PHARMACEUTICALS INC's ticker is SUPN and the CUSIP is 868459108. A total of 233 filers reported holding SUPERNUS PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 1.01 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2023 | $9,261 | +114.0% | 320 | +103.8% | 0.00% | – |
| Q3 2023 | $4,328 | -44.4% | 157 | -39.4% | 0.00% | – |
| Q2 2023 | $7,786 | +10.8% | 259 | +33.5% | 0.00% | – |
| Q1 2023 | $7,029 | +100314.3% | 194 | 0.0% | 0.00% | – |
| Q4 2022 | $7 | -99.9% | 194 | 0.0% | 0.00% | – |
| Q3 2022 | $7,000 | +600.0% | 194 | +397.4% | 0.00% | – |
| Q1 2022 | $1,000 | 0.0% | 39 | +95.0% | 0.00% | – |
| Q4 2021 | $1,000 | -99.9% | 20 | -42.9% | 0.00% | – |
| Q4 2018 | $1,163,000 | -34.0% | 35 | 0.0% | 0.00% | – |
| Q3 2018 | $1,762,000 | -15.9% | 35 | 0.0% | 0.00% | – |
| Q2 2018 | $2,095,000 | +30.7% | 35 | 0.0% | 0.00% | – |
| Q1 2018 | $1,603,000 | – | 35 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 426,500 | $11,754,340 | 3.96% |
| ASHFORD CAPITAL MANAGEMENT INC | 916,747 | $25,274,715 | 3.72% |
| ARMISTICE CAPITAL, LLC | 5,092,000 | $140,386,440 | 2.15% |
| S&T BANK/PA | 215,578 | $5,943 | 1.15% |
| Aristotle Capital Boston, LLC | 1,187,981 | $32,752,634 | 1.06% |
| RICE HALL JAMES & ASSOCIATES, LLC | 544,468 | $15,010,983 | 0.95% |
| Tributary Capital Management, LLC | 352,429 | $9,716,468 | 0.92% |
| Bridge City Capital, LLC | 65,297 | $1,800,238 | 0.91% |
| Integral Health Asset Management, LLC | 220,000 | $6,065,400 | 0.84% |
| Retirement Planning Co of New England, Inc. | 51,608 | $1,422,833 | 0.79% |